Miniaturized Droplet-Based Adaptation of the Ames Test for High-Throughput Mutagenicity Assessment.
This study demonstrates a new droplet microfluidic method for the Ames test that significantly reduces reagent use and improves throughput, though further validation in regulatory contexts is needed.
Where it sits
this study against the rest of the bofanglutide corpusSummary and findings
This study presents a droplet microfluidic adaptation of the Ames test for assessing mutagenicity using Salmonella typhimurium TA98. The optimal inoculum range was identified as 10^6-10^7 cells/mL, and dose-response analysis with 4-nitro-o-phenylenediamine showed cytotoxic suppression at ≥ 8 μg/mL. The microfluidic format reduced reagent consumption by over 90% and generated datasets within 48 hours.
Abstract
This work presents the first demonstration of a tube-based droplet microfluidic implementation of the Ames test, bridging single-droplet resolution with regulatory genotoxicity testing. The Ames test is a cornerstone assay for detecting mutagenicity, but conventional plate- and well-based formats suffer from high reagent consumption, low throughput, and limited automation. We report a droplet-based microfluidic Ames test assay using Salmonella typhimurium TA98, combining nanoliter compartmentalization with multiparameter optical detection. Cell density screening identified an optimal inoculum range of 10<sup>6</sup>-10<sup>7</sup> cells/mL that maximized sensitivity while limiting spontaneous revertants. Dose-response analysis with the reference mutagen 4-nitro-o-phenylenediamine (4-NOPD) revealed clear increases in the fraction of droplets with growth of revertants, followed by a cytotoxic suppression at ≥ 8 μg/mL. A threshold-based evaluation enabled robust quantification of stochastic mutation events at single-droplet resolution. Compared with the classical fluctuation assay, the microfluidic format reduced reagent consumption by > 90%, generated statistically powerful datasets within 48 h, and eliminated subjective scoring. This study establishes segmented-flow microfluidics as a scalable, sensitive, and resource-efficient platform for mutagenicity testing, with applications in regulatory toxicology, environmental monitoring, and high-throughput chemical screening.
Background
This paper addresses the need for improved methods in mutagenicity testing, specifically through the Ames test, which is widely used for detecting mutagenic substances. Traditional methods have limitations including high reagent use and low throughput. The introduction of a droplet microfluidic approach aims to enhance sensitivity and efficiency in regulatory genotoxicity testing.
Methods
The study utilized a tube-based droplet microfluidic implementation of the Ames test with Salmonella typhimurium TA98. The population consisted of bacterial cells screened for optimal density. The primary outcome was the dose-response relationship with the reference mutagen 4-nitro-o-phenylenediamine, assessed through optical detection.
Results
The optimal inoculum range was determined to be 10^6-10^7 cells/mL. Dose-response analysis indicated that cytotoxic suppression occurred at concentrations of 4-nitro-o-phenylenediamine at ≥ 8 μg/mL. The microfluidic method achieved a reduction in reagent consumption by over 90% and produced statistically powerful datasets within 48 hours.
Interpretation
The findings suggest that the microfluidic Ames test offers significant improvements over traditional methods, particularly in terms of resource efficiency and speed. However, while the statistical significance of the results is clear, the clinical relevance of the findings in a regulatory context remains to be fully established. Limitations such as the lack of long-term data and potential confounding factors in the assay design may affect the generalizability of the results.
Key findings
- Optimal inoculum range of 10^6-10^7 cells/mL identified.
- Cytotoxic suppression observed at ≥ 8 μg/mL of 4-nitro-o-phenylenediamine.
- Reagent consumption reduced by > 90% compared to classical methods.
- Statistically powerful datasets generated within 48 hours.
- Single-droplet resolution enabled robust quantification of mutation events.
Limitations
- Not reported in abstract.
- Single-species model used, limiting generalizability.
- Short follow-up period of 48 hours.
- Potential confounding factors not fully addressed.